Download PDF
Thromb Haemost 1996; 76(04): 628-630
DOI: 10.1055/s-0038-1650634
Letters to the Editor
Schattauer GmbH Stuttgart

Low Molecular Weight Heparin for Thromboprophylaxis during Pregnancy in 2 Patients with Mechanical Mitral Valve Replacement

L H Lee
The Department of Haematology, Department of Obstetrics and Gynaecology, Department of Cardiology, Singapore General Hospital, Singapore
,
P C Y Liauw
The Department of Haematology, Department of Obstetrics and Gynaecology, Department of Cardiology, Singapore General Hospital, Singapore
,
A S H Ng
The Department of Haematology, Department of Obstetrics and Gynaecology, Department of Cardiology, Singapore General Hospital, Singapore
› Author Affiliations
Further Information

Publication History

Received 26 March 1996

Accepted after revision 28 May 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Hirsh J, Levine MN. Low Molecular Weight Heparin. Blood 1992; 79: 1-17
    PubMedGoogle Scholar
  • 2 Hall RG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122-140
    CrossrefPubMedGoogle Scholar
  • 3 Flessa HC, Kopstrom AB, Glucck III, Will JJ. Placental transport of heparin. Am J Obstet Gynecol 1965; 93: 570-573
    CrossrefPubMedGoogle Scholar
  • 4 Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during longterm heparin treatment: A radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221-228
    CrossrefPubMedGoogle Scholar
  • 5 De Swiet M, Ward PD, Fidler J, Horsman A, Katz D, Letsky E, Peacock M, Wise PH. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol 1983; 90: 1129-1134
    CrossrefPubMedGoogle Scholar
  • 6 Cimo PL, Moake JL, Weinger RS, Ben Menachem YB, Khalis KG. Heparin-induced thrombocytopenia associated with platelet aggregating antibodies and arterial thrombosis. Am J Haematol 1979; 6: 125-133
    CrossrefPubMedGoogle Scholar
  • 7 Omri A, Delaloye JF, Anderson H, Bachmann F. Low Molecular Weight Heparin Novo (LHN-1) Does Not Cross the Placenta During the Second Trimester of Pregnancy. Thromb Haemost 1989; 1: 55-56
    PubMedGoogle Scholar
  • 8 Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou C, Pemberton KD, Nicolaides KH, Barrett JJ, Kakkar VV. Use of Low Molecular Weight Heparin in Pregnancy. Thromb Haemost 1992; 68: 652-656
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Nelson-Piercy C. Low molecular weight heparin for obstetric thromboprophylaxis. Br J Obstet Gynaecol 1994; 101: 6-8
    CrossrefPubMedGoogle Scholar
  • 10 Barradell LB, Buckley MM. Nadoparin Calcium. A Review of its Pharmacology and Clinical Applications in the Prevention and Treatment of Thromboembolic Disorders. Drugs 1992; 44: 858-888
    CrossrefPubMedGoogle Scholar
  • 11 Prandoni P, Lensing AWA, Buller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, Ten Cate JW. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339: 441-445
    CrossrefPubMedGoogle Scholar
  • 12 Lopaciuk S, Meissner AJ, Filipecki S, Zalwilska K, Sowier J, Ciesielski L, Bielawiec M, Glowinski S, Czestochowska E. and others. Subcutaneous Low Molecular Weight Heparin versus Subcutaneous Unfractionated Heparin in the Treatment od Deep Vein Thrombosis: a Polish Multicentre Trial. Thromb Haemost 1992; 68: 14-18
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force. Guidelines on oral anticoagulation: Second edition. J Clin Pathol 1990; 43: 177-183
    PubMedGoogle Scholar
  • 14 Hirsh J. Oral anticoagulation drugs. N Engl J Med 1991; 324: 1865-1875
    CrossrefPubMedGoogle Scholar
  • 15 Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women. Thromb Haemost 1990; 63: 319-320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Gillis S, Shushan A, Eldor A. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int J Gynecol Obstet 1992; 39: 297-301
    CrossrefPubMedGoogle Scholar
  • 17 Sturridge F, De Swiet M, Letsky E. The use of low molecular heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol 1994; 101: 69-71
    CrossrefPubMedGoogle Scholar
  • 18 Monreal M, Olive A, Lafoz E. Heparins, coumarin and bone density. Lancet 1991; 338: 706
    PubMedGoogle Scholar